Business Description
Bio Vitos Pharma AB
ISIN : SE0023286919
Compare
Compare
Traded in other countries / regions
BIOVIT.Sweden IPO Date
2017-03-15Description
Bio Vitos Pharma AB Formelry Hemcheck Sweden AB is a Sweden based medical technology company. It is developing a product addressing the issue of hemolyzed blood samples.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.99 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 42.91 | |||||
| Beneish M-Score | 1.45 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 49.8 | |||||
| 3-Year EBITDA Growth Rate | 41.6 | |||||
| 3-Year EPS without NRI Growth Rate | 59.5 | |||||
| 3-Year FCF Growth Rate | 51.2 | |||||
| 3-Year Book Growth Rate | -59.9 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 24.07 | |||||
| 9-Day RSI | 30.75 | |||||
| 14-Day RSI | 34.18 | |||||
| 6-1 Month Momentum % | -0.38 | |||||
| 12-1 Month Momentum % | -47.15 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 8.5 | |||||
| Quick Ratio | 5.84 | |||||
| Cash Ratio | 2.53 | |||||
| Days Inventory | 458.76 | |||||
| Days Sales Outstanding | 148.1 | |||||
| Days Payable | 183.07 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -147.7 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 24.73 | |||||
| Operating Margin % | -1339.75 | |||||
| Net Margin % | -1334.08 | |||||
| FCF Margin % | -475.72 | |||||
| ROE % | -58.48 | |||||
| ROA % | -49.88 | |||||
| ROIC % | -48.32 | |||||
| ROC (Joel Greenblatt) % | -1001.69 | |||||
| ROCE % | -58.48 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 9.72 | |||||
| PB Ratio | 0.7 | |||||
| Price-to-Tangible-Book | 6.32 | |||||
| EV-to-EBIT | -1.63 | |||||
| EV-to-EBITDA | -4.94 | |||||
| EV-to-Revenue | 21.7 | |||||
| EV-to-FCF | -4.56 | |||||
| Price-to-Net-Current-Asset-Value | 7.9 | |||||
| Price-to-Net-Cash | 31.6 | |||||
| Earnings Yield (Greenblatt) % | -61.35 | |||||
| FCF Yield % | -21.24 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bio Vitos Pharma AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 1.112 | ||
| EPS (TTM) (kr) | -1.373 | ||
| Beta | 2.79 | ||
| Volatility % | 184.98 | ||
| 14-Day RSI | 34.18 | ||
| 14-Day ATR (kr) | 0.097095 | ||
| 20-Day SMA (kr) | 0.7726 | ||
| 12-1 Month Momentum % | -47.15 | ||
| 52-Week Range (kr) | 0.6 - 6.95 | ||
| Shares Outstanding (Mil) | 39.4 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bio Vitos Pharma AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bio Vitos Pharma AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bio Vitos Pharma AB Frequently Asked Questions
What is Bio Vitos Pharma AB(OSTO:BIOVIT)'s stock price today?
The current price of OSTO:BIOVIT is kr0.63. The 52 week high of OSTO:BIOVIT is kr6.95 and 52 week low is kr0.60.
When is next earnings date of Bio Vitos Pharma AB(OSTO:BIOVIT)?
The next earnings date of Bio Vitos Pharma AB(OSTO:BIOVIT) is 2025-02-14.
Does Bio Vitos Pharma AB(OSTO:BIOVIT) pay dividends? If so, how much?
Bio Vitos Pharma AB(OSTO:BIOVIT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers